Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the efficacy and safety of GC6101A in gastritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• GC6101A

Snippet

Sponsor: Green Cross Corporation | Conditions: Gastritis | Phase 2 | Status: UNKNOWN